eISSN: 1897-4295
ISSN: 1734-9338
Advances in Interventional Cardiology/Postępy w Kardiologii Interwencyjnej
Current issue Archive Manuscripts accepted About the journal Editorial board Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
vol. 7

Association on cardiovascular interventions of PCS
Current status of drug-eluting stents and drug-eluting balloons in patients with stable coronary artery disease: An expert consensus document of the Association for Percutaneous Cardiovascular Interventions and Polish Cardiac Society

Adam Witkowski
Maksymilian P. Opolski
Dariusz Dudek
Maciej Lesiak
Jacek Legutko
Wojciech Wojakowski
Andrzej Ochała
Paweł Maciejewski
Tomasz Deptuch
Aleksander Araszkiewicz
Dariusz Ciećwierz

Post Kardiol Interw 2011; 7, 1 (23): 20-55
Online publish date: 2011/04/08
View full text Get citation
Despite a dramatic reduction in restenosis and target vessel revascularization rates by drug-eluting stents (DES), conflicting concerns have been raised over the risk of late DES thrombosis when compared to bare-metal stents. Certainly, the heterogeneity of DES results from the introduction of a great variety of new DES types with diverse efficacy and safety parameters. Furthermore, there is a steady increase in DES availability without parallel and robust data from randomized clinical trials. Thus, the postulated class effect of DES should be regarded as non-obligatory. This article is based on 110 randomized DES trials performed on 72 305 patients. Current status of DES and guidelines for DES implantation in various clinical scenarios are discussed.

drug-eluting stents, drug-eluting balloons, randomized clinical trials

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.